DIVA Laboratories, Ltd. (TPEX:4153)
Taiwan · Delayed Price · Currency is TWD 40.65
0.00 (0.00%)
Aug 14, 2025, 1:30 PM CST
DIVA Laboratories Market Cap
DIVA Laboratories has a market cap or net worth of 2.38 billion as of August 14, 2025. Its market cap has decreased by -15.66% in one year.
Market Cap
2.38B
Enterprise Value
1.74B
Revenue
859.02M
Ranking
n/a
PE Ratio
26.92
Stock Price
40.65
Market Cap Chart
Since October 11, 2010, DIVA Laboratories's market cap has increased from 425.72M to 2.38B, an increase of 460.19%. That is a compound annual growth rate of 12.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 2.38B | 6.27% |
| Dec 31, 2024 | 2.24B | 3.94% |
| Dec 29, 2023 | 2.16B | -9.25% |
| Dec 30, 2022 | 2.38B | 51.31% |
| Dec 30, 2021 | 1.57B | 8.06% |
| Dec 31, 2020 | 1.45B | -31.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 207.84B |
| PharmaEssentia | 167.97B |
| Bora Pharmaceuticals Co., LTD. | 90.60B |
| Lotus Pharmaceutical | 54.57B |
| Oneness Biotech | 30.94B |
| Polaris Group | 27.70B |
| Center Laboratories | 26.60B |
| Lumosa Therapeutics | 25.91B |